Effects of prolonged interruption of rehabilitation routines in amyotrophic lateral sclerosis patients
- 4 May 2021
- journal article
- research article
- Published by Cambridge University Press (CUP) in Palliative & Supportive Care
- Vol. 20 (3), 369-374
- https://doi.org/10.1017/s1478951521000584
Abstract
Objective Patients with amyotrophic lateral sclerosis (ALS) experienced prolonged interruption of their rehabilitation palliative care routines due to restrictive COVID-19 pandemic public health measures. This study assesses the effects of before and after the lockdown on functionality rates and quality of life (QoL) in patients with ALS. Methods A longitudinal observational study was conducted. Participants were assessed three times — early January (T0), before mandatory lockdown (T1), and during lockdown (T2) — using the ALS Functional Rating Scale-revised (ALSFRS-R), Fatigue Severity Scale (FSS), and the ALS-Specific Quality of Life-Short Form (ALSSQOL-SF). The paired-sample t-test and Wilcoxon signed-rank test were used. Results Thirty-two patients were included with a mean age of 56.9 (SD 14.2) years and mean symptoms onset of 27.1 (SD 14.3) months. ALSFRS-R mean scores decayed significantly over time when comparing T0–T1 (0.26 ± 0.38) and T1–T2 (1.36 ± 1.43) slopes (p < 0.001). Significant differences were observed between T1 and T2 for ALSSQOL-SF scores (115.31 ± 17.06 vs. 104.31 ± 20.65), especially in four specific domains, and FSS scores (34.06 ± 16.84 vs. 40.09 ± 17.63). Negative correlations between negative emotions and physical symptoms assessed by ALSSQOL-SF and FSS were found. Significance of the results Rehabilitation treatment routines in palliative care, such as physiotherapy and speech therapy, appear to mitigate the ALSFRS-R slope. Prolonged interruption of rehabilitation during the lockdown may have accelerated the functional decline in ALS patients’ motor skills with as measured after 2 months by the ALSFRS-R in the limb and bulbar subscores, but not respiratory subscore. Other short-term effects, increased fatigue and negative impact on QoL, were also verified.Keywords
This publication has 43 references indexed in Scilit:
- Amyotrophic lateral sclerosis care and research in the United States during the COVID‐19 pandemic: Challenges and opportunitiesMuscle & Nerve, 2020
- Classifying Patients with Amyotrophic Lateral Sclerosis by Changes in FVC. A Group-based Trajectory AnalysisAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Physical therapy for individuals with amyotrophic lateral sclerosis: current insightsDegenerative Neurological and Neuromuscular Disease, 2018
- The Role of Moderate Aerobic Exercise as Determined by Cardiopulmonary Exercise Testing in ALSNeurology Research International, 2018
- Adaptive equipment use by people with motor neuron disease in Australia: a prospective, observational consecutive cohort studyDisability and Rehabilitation: Assistive Technology, 2017
- Assessment of the factorial validity and reliability of the ALSFRS-R: a revision of its measurement modelZeitschrift für Neurologie, 2017
- Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published LiteratureNeuroepidemiology, 2013
- Exercise and amyotrophic lateral sclerosisNeurological Sciences, 2012
- EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task forceEuropean Journal of Neurology, 2011
- A cross sectional study on determinants of quality of life in ALSJournal of Neurology, Neurosurgery & Psychiatry, 2004